Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage

Molecular and Cellular Biology

Volumn 20, Issue 8, 2000, Pages 2803-2808

  Webley, Katherine ^a   Bond, Jane A ^a   Jones, Christopher J ^a   Blaydes, Jeremy P ^b   Craig, Ashley ^b   Hupp, Ted ^b   Wynford Thomas, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN P53;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; FIBROBLAST; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

CELL LINE; DNA DAMAGE; DNA REPLICATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0034114544     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.8.2803-2808.2000     Document Type: Article

References (59)

1. Atadja, P., H. Wong, I. Garkavtsev, C. Geillette, and K. Riabowol. 1995. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92:8348-8352.
2. Bacchetti, S., and C. M. Counter. 1995. Telomeres and telomerase in human cancer. Int. J. Oncol. 7:423-432.
3. Blaydes, J. P., and T. Hupp. 1998. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site. Oncogene 17:1045-1052.
4. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C.-P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
5. Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889.
6. Bond, J. A., J. P. Blaydes, J. Rowson, M. F. Haughton, J. K. Smith, D. Wynford-Thomas, and F. S. Wyllie. 1995. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SD11/WAF1. Cancer Res. 55:2404-2409.
7. Bond, J. A., M. Haughton, J. Blaydes, V. Gire, D. Wynford-Thomas, and F. Wyllie. 1996. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13:2097-2104.
8. Bond, J. A., K. Webley, F. S. Wyllie, C. J. Jones, A. Craig, T. Hupp, and D. Wynford-Thomas. 1999. p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts. Oncogene 18:3788-3792.
9. Bottger, V., A. Bottger, S. F. Howard, S. M. Picksley, P. Chene, C. Carcia-Echeverria, H.-K. Hochkeppel, and D. P. Lane. 1996. Identification of novel mdm2 binding peptides by phage display. Oncogene 13:2141-2147.
10. Bottger, V., A. Bottger, C. Garcia-Echeverria, Y. Ramos, A. van der Eb, A. Jochemsen, and D. Lane. 1999. Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene 18:189-199.
11. Campisi, J. 1997. The biology of replicative senescence. Eur. J. Cancer 33:703-709.
12. Canman, C. E., A. C. Wolff, C. Y. Chen, A. J. Fornace, Jr., and M. B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxiatelangiectasia. Cancer Res. 54:5054-5058.
13. Craig, A., J. Blaydes, L. Burch, A. Thompson, and T. Hupp. 1999. Dephosphorylation of human p53 at serine20 following cellular exposure to low levels of non-ionizing radiation. Oncogene 18:6305-6312.
14. Craig, A. L., L. Burch, B. Vojtesek, J. Mikutowska, A. Thompson, and T. R. Hupp. 1999. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem. J. 342:133-141.
15. de Lange, T. 1995. Telomere dynamics and genome instability in human cancer. Cold Spring Harbor Monogr. Ser. 10:1-27.
16. Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
17. Garkavtsev, I., and K. Riabowol. 1997. Extension of the replicative lifespan of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol. Cell. Biol. 17:2014-2019.
18. Garkavtsev, I., I. A. Grigorian, V. S. Ossovskaya, M. V. Chernov, P. M. Chumakov, and A. V. Gudkov. 1998. The candidate tumour suppressor p33INK1 cooperates with p53 in cell growth control. Nature 391:295-298.
19. Giaccia, A. J., and M. B. Kastan. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973-2983.
20. Gire, V., and D. Wynford-Thomas. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell. Biol. 18:1611-1621.
21. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
22. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-636.
23. Hupp, T. R., and D. P. Lane. 1994. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harbor Symp. Quant. Biol. 59:195-206.
24. Hupp, T. R., and D. P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4:865-875.
25. Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83:237-245.
26. Jimenez, G. S., F. Bryntesson, M. I. Torres-Arzayus, A. Priestley, M. Beeche, S. Saito, K. Sakaguchi, E. Appella, P. A. Jeggo, G. E. Taccioli, G. M. Wahl, and M. Hubank. 1999. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400:81-83.
27. Kapoor, M., and G. Lozano. 1998. Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. USA 95:2834-2837.
28. Khanna, K. K., K. E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S. P. Lees-Miller, and M. F. Lavin. 1998. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20:398-400.
29. Kulju, K. S., and J. M. Lehman. 1995. Increased p53 protein associated with aging in human diploid fibroblasts. Exp. Cell Res. 217:336-345.
30. Lakin, N., B. Hann, and S. Jackson. 1999. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene 18:3989-3995.
31. Lane, D. P. 1992. p53, guardian of the genome. Nature 358:15-16.
32. Lin, J., A. K. Teresky, and A. J. Levine. 1995. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10:2387-2390.
33. Linke, S. P., K. C. Clarkin, and G. M. Wahl. 1997. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 57:1171-1179.
34. Linskens, M. H., J. Feng, W. H. Andrews, B. E. Enlow, S. M. Saati, L. A. Tonkin, W. D. Funk, and B. Villeponteau. 1995. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 23:3244-3251.
35. Lu, H., Y. Taya, M. Ikeda, and A. J. Levine. 1998. Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc. Natl. Acad. Sci. USA 95:6399-6402.
36. Milner, J., and J. V. Watson. 1990. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. Oncogene 5:1683-1690.
37. Mundt, M., T. Hupp, M. Fritsche, C. Merkle, S. Hansen, D. Lane, and B. Groner. 1997. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene 15:237-244.
38. Parkinson, E. K., R. F. Newbold, and W. N. Keith. 1997. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur. J. Cancer 33:727-734.
39. Prives, C. 1998. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5-8.
40. Prives, C., and P. Hall. 1999. The p53 pathway. J. Pathol. 187:112-126.
41. Robles, S. J., and G. R. Adami. 1998. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16:1113-1123.
42. Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831-2841.
43. Shaw, P., J. Freeman, R. Bovey, and R. Iggo. 1996. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12:921-930.
44. Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
45. Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471-3481.
46. Stephen, C. W., P. Helminen, and D. P. Lane. 1995. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J. Mol. Biol. 248:58-78.
47. Takenaka, I., F. Morin, B. R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270:5405-5411.
48. Tibbetts, R. S., K. M. Brumbaugh, J. M. Williams, J. N. Sarkaria, W. A. Cliby, S. Y. Shieh, Y. Taya, C. Prives, and R. T. Abraham. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157.
49. van Steensel, B., A. Smogorzewska, and T. de Lange. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413.
50. Vaziri, H., M. D. West, R. C. Allsopp, T. S. Davison, Y.-S. Wu, C. H. Arrowsmith, G. G. Poirier, and S. Benchimol. 1997. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly (ADP-ribose) polymerase. EMBO J. 16:6018-6033.
51. Vojtesek, B., J. Bartek, C. A. Midgley, and D. P. Lane. 1992. An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods 151:237-244.
52. Vojtesek, B., H. Dolezalova, L. Lauerova, M. Svitakova, P. Havlis, J. Kovarik, C. A. Midgley, and D. P. Lane. 1995. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene 10:389-393.
53. Waterman, M. J., E. S. Stavridi, J. L. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175-178.
54. Woo, R. A., K. G. McLure, S. P. Lees-Miller, D. E. Rancourt, and P. W. K. Lee. 1998. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394:700-704.
55. Wright, W. E., and J. W. Shay. 1995. Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends Cell Biol. 5:293-297.
56. Wyllie, F. S., M. F. Haughton, J. A. Bond, J. M. Rowson, C. J. Jones, and D. Wynford-Thomas. 1996. S phase cell-cycle arrest following DNA damage is independent of the p53/p21 WAF1 signalling pathway. Oncogene 12:1077-1082.
57. Wyllie, F. S., C. J. Jones, J. W. Skinner, M. F. Haughton, C. Wallis, D. Wynford-Thomas, R. G. Farragher, and D. Kipling. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24:16-17.
58. Wynford-Thomas, D., J. A. Bond, F. S. Wyllie, and C. J. Jones. 1995. Does telomere shortening drive selection for p53 mutation in human cancer? Mol. Carcinog. 12:119-123.
59. Wynford-Thomas, D. 1997. Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur. J. Cancer 33:716-726.